GO:0032725 positive regulation of granulocyte macrophage colony-stimulating factor production: Immune Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032725 describes any process that activates or increases the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor (GM-CSF) production.
• GM-CSF is a pleiotropic cytokine that regulates the survival, proliferation, and activation of myeloid cells, including macrophages, neutrophils, and dendritic cells.
• Positive regulation of GM-CSF production is critical in inflammatory diseases, cancer, and autoimmune conditions, where GM-CSF levels influence disease progression.
• Key transcription factors such as PEBP2 (AML1) can both positively and negatively regulate GM-CSF promoter activity, highlighting complex transcriptional control.
• Endothelial cells constitutively produce GM-CSF, and this production is controlled by positive and negative regulatory elements.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of genes that regulate GM-CSF production, aiding therapeutic target discovery.
Description
Granulocyte macrophage colony-stimulating factor (GM-CSF) is a cytokine that controls the differentiation, survival, and function of myeloid cells such as macrophages, neutrophils, and dendritic cells. The production of GM-CSF is tightly regulated at transcriptional and post-transcriptional levels, and its dysregulation contributes to various inflammatory and malignant diseases. The Gene Ontology term GO:0032725, positive regulation of granulocyte macrophage colony-stimulating factor production, captures the biological processes that enhance the synthesis and secretion of GM-CSF. Understanding this term is essential for researchers studying immune regulation, host defense, and cancer immunology. For example, GM-CSF enhances the pro-inflammatory response of macrophages to Pseudomonas aeruginosa infection, and it also activates neutrophils to express B7-H4, which correlates with gastric cancer progression. Moreover, GM-CSF directly affects adaptive immunogenesis, influencing T cell responses. Thus, elucidating the molecular mechanisms that positively regulate GM-CSF production can reveal new therapeutic targets for infectious diseases, autoimmunity, and cancer.
positive regulation of granulocyte macrophage colony-stimulating factor production At A Glance
| GO ID | GO:0032725 |
|---|---|
| GO term | positive regulation of granulocyte macrophage colony-stimulating factor production |
| Ontology | biological_process |
| Synonym | activation of granulocyte macrophage colony-stimulating factor production; positive regulation of GM-CSF production; stimulation of granulocyte macrophage colony-stimulating factor production; upregulation of granulocyte macrophage colony-stimulating factor production |
| Major function | Upregulates the production of GM-CSF, a cytokine that drives myeloid cell differentiation, activation, and survival. |
| Related GO terms | regulation of granulocyte macrophage colony-stimulating factor production; positive regulation of cytokine production |
| Taxonomic range | Eukaryota |
| Cellular location | Extracellular space; cytoplasm; nucleus (for regulatory events) |
What Is GO:0032725?
According to the Gene Ontology, GO:0032725 (positive regulation of granulocyte macrophage colony-stimulating factor production) is defined as any process that activates or increases the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production. This biological process encompasses molecular events that upregulate the biosynthesis and secretion of GM-CSF, including transcriptional activation, mRNA stabilization, and enhanced protein secretion. It is a child of positive regulation of cytokine production and is distinct from negative regulation of GM-CSF production.
Why Is positive regulation of granulocyte macrophage colony-stimulating factor production Important in Cell Biology?
Positive regulation of GM-CSF production is a central node in immune responses and inflammation. GM-CSF is produced by many cell types, including endothelial cells, macrophages, and T cells, and its levels are elevated in autoimmune diseases, chronic inflammation, and cancer. The cytokine enhances antigen presentation and pro-inflammatory macrophage functions, which can be protective against infections but also exacerbate tissue damage. In cancer, GM-CSF can promote tumor progression by activating immunosuppressive neutrophils that express B7-H4. Therefore, understanding the positive regulation of GM-CSF production is crucial for developing therapies that either boost immunity against pathogens or dampen pathological inflammation.
• GM-CSF is a key driver of myeloid cell differentiation and activation, essential for host defense.
• Positive regulation of GM-CSF production is implicated in autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.
• In cancer, GM-CSF can promote tumor progression by recruiting immunosuppressive cells.
• GM-CSF enhances pro-inflammatory responses of macrophages to bacterial infection, such as Pseudomonas aeruginosa.
• Endothelial cells constitutively produce GM-CSF, and its regulation involves positive and negative elements.
• Transcription factors like PEBP2 (AML1) can both activate and repress GM-CSF promoter activity, indicating complex regulation.
• GM-CSF directly affects adaptive immunity by modulating T cell responses.
• Dysregulated GM-CSF production is linked to myocardial ischemia/reperfusion injury through macrophage polarization.
• Targeting GM-CSF signaling is a therapeutic strategy in inflammatory diseases and cancer.
• CRISPR screening can identify novel regulators of GM-CSF production for drug discovery.
What Happens During positive regulation of granulocyte macrophage colony-stimulating factor production?
Transcriptional Activation of the GM-CSF Gene
In simple terms: This step involves turning on the gene that makes GM-CSF.
The GM-CSF gene (CSF2) is transcriptionally activated by various stimuli, including inflammatory cytokines and pathogen-associated molecular patterns. Transcription factors such as PEBP2 (AML1) bind to the GM-CSF promoter and can either activate or repress transcription depending on context. Positive regulatory elements in the promoter respond to signals like TNF-alpha and IL-1, leading to increased GM-CSF mRNA synthesis. This transcriptional upregulation is a primary mechanism for positive regulation of GM-CSF production.
Post-transcriptional Stabilization of GM-CSF mRNA
In simple terms: After the gene is turned on, the mRNA message is protected from degradation to make more protein.
GM-CSF mRNA contains AU-rich elements in its 3' untranslated region that regulate its stability. Positive regulation can occur through stabilization of this mRNA, increasing its half-life and allowing more protein translation. Although specific RNA-binding proteins are not detailed in the provided citations, this is a general mechanism for cytokine regulation.
Secretion and Extracellular Accumulation
In simple terms: The produced GM-CSF is released outside the cell to act on other cells.
GM-CSF is secreted into the extracellular space where it binds to its receptor on target cells. Positive regulation of production leads to increased secretion, as observed in endothelial cells that constitutively release GM-CSF. This secreted GM-CSF then acts on macrophages, neutrophils, and dendritic cells to enhance their functions.
Feedback and Amplification Loops
In simple terms: The process can feed back on itself to amplify the response.
GM-CSF can stimulate its own production indirectly through activation of immune cells. For example, GM-CSF-activated neutrophils express B7-H4, which may influence the tumor microenvironment and further modulate cytokine production. Additionally, GM-CSF enhances pro-inflammatory responses of macrophages, which can lead to increased GM-CSF release, creating a positive feedback loop.
Key Genes Involved in GO:0032725 positive regulation of granulocyte macrophage colony-stimulating factor production
The following genes and proteins are involved in the positive regulation of GM-CSF production, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CSF2 | Encodes GM-CSF cytokine | Central to the process; mutations affect production levels |
| PEBP2 (AML1) | Transcription factor regulating GM-CSF promoter | Both positive and negative regulation |
| Dectin-1 | Pattern recognition receptor | Regulates macrophage polarization and neutrophil infiltration |
| IFN-γ | Cytokine that enhances macrophage responses | Synergizes with GM-CSF to boost pro-inflammatory responses |
| B7-H4 | Immune checkpoint molecule | Expressed on GM-CSF-activated neutrophils; correlates with cancer progression |
| G-CSF | Another colony-stimulating factor | Can modulate macrophage function and cytokine production |
| IL-6 | Pro-inflammatory cytokine | Induced by G-CSF in macrophages; may influence GM-CSF regulation |
| TNF-α | Pro-inflammatory cytokine | Often co-regulated with GM-CSF in inflammation |
| IL-1β | Pro-inflammatory cytokine | Stimulates GM-CSF production in various cell types |
| NF-κB | Transcription factor | Commonly activated in GM-CSF induction pathways |
| STAT3 | Transcription factor | Downstream of GM-CSF signaling; may feedback on production |
| STAT5 | Transcription factor | Mediates GM-CSF receptor signaling |
| IRF1 | Transcription factor | Regulates cytokine production in macrophages |
| PU.1 | Transcription factor | Essential for myeloid cell development and GM-CSF expression |
| C/EBPβ | Transcription factor | Regulates GM-CSF promoter activity |
| AP-1 | Transcription factor | Cooperates with other factors to activate GM-CSF transcription |
| MAPK | Signaling kinase | Pathway involved in GM-CSF induction |
How Is positive regulation of granulocyte macrophage colony-stimulating factor production Regulated?
The positive regulation of GM-CSF production is controlled by multiple signaling pathways and transcription factors. Inflammatory stimuli such as TNF-α and IL-1β activate NF-κB and AP-1, which bind to the GM-CSF promoter and enhance transcription. The transcription factor PEBP2 (AML1) can both activate and repress GM-CSF promoter activity, depending on the cellular context and interacting cofactors. Additionally, GM-CSF signaling itself can activate STAT3 and STAT5, which may feed back to modulate further production. Endothelial cells constitutively produce GM-CSF, and this production is controlled by positive and negative regulatory elements in the promoter. In macrophages, IFN-γ enhances GM-CSF-induced pro-inflammatory responses, suggesting cross-regulation between cytokine pathways.
positive regulation of granulocyte macrophage colony-stimulating factor production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CSF2 | Inflammatory diseases, cancer | Knockout mice; overexpression cell lines |
| PEBP2 (AML1) | Leukemia, immune dysregulation | Point mutation knock-in mice; CRISPR knockout |
| Dectin-1 | Myocardial ischemia/reperfusion injury | Knockout mice; macrophage-specific deletion |
| B7-H4 | Gastric cancer progression | Knock-in reporter cells; overexpression models |
| IFN-γ | Infectious diseases, autoimmunity | Knockout mice; CRISPR knockout in macrophages |
Cancer Progression and Immunosuppression
GM-CSF plays a dual role in cancer. On one hand, it can stimulate anti-tumor immunity by activating dendritic cells. On the other hand, GM-CSF-activated neutrophils express B7-H4, an immune checkpoint molecule that correlates with gastric cancer progression and poor patient survival. Thus, positive regulation of GM-CSF production can contribute to an immunosuppressive tumor microenvironment. Targeting GM-CSF signaling is being explored as a therapeutic strategy in various cancers.
Inflammatory and Autoimmune Diseases
Excessive GM-CSF production is associated with chronic inflammatory diseases such as rheumatoid arthritis and multiple sclerosis. GM-CSF enhances the pro-inflammatory response of macrophages to pathogens like Pseudomonas aeruginosa, which can exacerbate tissue damage. In myocardial ischemia/reperfusion injury, Dectin-1 contributes to injury by regulating macrophage polarization and neutrophil infiltration, processes in which GM-CSF is likely involved. Therefore, inhibiting positive regulation of GM-CSF production may be beneficial in these conditions.
Infectious Diseases
GM-CSF is critical for host defense against infections. It enhances the antimicrobial functions of macrophages and neutrophils. For example, GM-CSF enhances the pro-inflammatory response of IFN-γ-treated macrophages to Pseudomonas aeruginosa infection, aiding bacterial clearance. However, excessive GM-CSF can also lead to immunopathology. Understanding the positive regulation of GM-CSF production is important for developing therapies that balance protective immunity and tissue damage.
From positive regulation of granulocyte macrophage colony-stimulating factor production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate GM-CSF production? | CRISPR knockout in primary macrophages or cell lines |
| Does a specific point mutation in gene Y affect GM-CSF levels? | Point mutation knock-in via CRISPR |
| How does overexpression of gene Z affect GM-CSF secretion? | CRISPR activation or lentiviral overexpression |
| What is the dynamics of GM-CSF promoter activation? | Tagged knock-in of fluorescent reporter at CSF2 locus |
| Which genes are essential for GM-CSF production? | Genome-wide CRISPR library screening |
| How does GM-CSF production change in disease models? | Patient-derived organoids or mouse models |
How to Study the positive regulation of granulocyte macrophage colony-stimulating factor production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | mRNA levels of CSF2 and other genes | Transcriptional profiling |
| ELISA | Secreted GM-CSF protein | Quantification of production |
| Proteomics | Global protein changes | Pathway analysis |
| CRISPR knockout screening | Gene essentiality for GM-CSF production | Target discovery |
| CRISPR activation screening | Genes that enhance GM-CSF production | Pathway activation |
| Flow cytometry | Intracellular GM-CSF staining | Single-cell analysis |
| Reporter assays | Promoter activity | Dynamic regulation |
| ChIP-seq | Transcription factor binding at CSF2 locus | Mechanistic studies |
Transcriptional Profiling by RNA-seq
RNA sequencing can quantify GM-CSF mRNA levels and identify global transcriptional changes upon positive regulation. This method is useful for discovering novel regulators and pathways.
Protein Quantification by ELISA and Proteomics
ELISA measures secreted GM-CSF protein in culture supernatants, while mass spectrometry-based proteomics can identify co-regulated proteins. These methods validate production changes.
CRISPR Screening for Regulators
Genome-wide CRISPR knockout or activation screens can identify genes that positively or negatively regulate GM-CSF production. This unbiased approach is powerful for discovering new therapeutic targets.
Imaging and Reporter Assays
Fluorescent reporter knock-in at the CSF2 locus allows real-time monitoring of GM-CSF promoter activity and production dynamics in live cells.
How CRISPR Can Be Used to Study GO:0032725 positive regulation of granulocyte macrophage colony-stimulating factor production
Knockout
CRISPR knockout of candidate genes (e.g., PEBP2, Dectin-1) can determine whether they are required for positive regulation of GM-CSF production. For example, knocking out Dectin-1 may reduce GM-CSF levels in models of myocardial injury.
Point Mutation
Introducing specific point mutations in transcription factor binding sites of the CSF2 promoter can reveal regulatory elements. This approach helps dissect the contribution of individual residues to GM-CSF production.
Knock-in
Knock-in of fluorescent reporters (e.g., GFP) at the CSF2 locus enables real-time tracking of GM-CSF expression. This is valuable for high-throughput screening and live imaging.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of candidate genes can test whether they are sufficient to enhance GM-CSF production. This is useful for identifying positive regulators.
How EDITGENE Supports positive regulation of granulocyte macrophage colony-stimulating factor production Research
Researchers studying positive regulation of granulocyte macrophage colony-stimulating factor production-related genes often need to determine whether a candidate gene is causally involved in GM-CSF regulation. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of granulocyte macrophage colony-stimulating factor production research.
Frequently Asked Questions About positive regulation of granulocyte macrophage colony-stimulating factor production
What is GO:0032725?
GO:0032725 is the Gene Ontology term for positive regulation of granulocyte macrophage colony-stimulating factor production, describing processes that increase GM-CSF production.
What genes are involved in positive regulation of GM-CSF production?
Key genes include CSF2 (encoding GM-CSF), PEBP2 (AML1), Dectin-1, IFN-γ, and B7-H4, among others.
How is GM-CSF production regulated?
GM-CSF production is regulated at transcriptional and post-transcriptional levels by transcription factors like PEBP2 and inflammatory signals.
What diseases are associated with GM-CSF overproduction?
GM-CSF overproduction is linked to inflammatory diseases, autoimmune conditions, and cancer progression.
What methods are used to study GM-CSF production?
Methods include RNA-seq, ELISA, proteomics, CRISPR screening, and reporter assays.
Can CRISPR be used to study GM-CSF regulation?
Yes, CRISPR knockout, knock-in, and activation models are powerful tools to dissect GM-CSF regulatory networks.
What is the role of PEBP2 in GM-CSF production?
PEBP2 (AML1) can both activate and repress GM-CSF promoter activity, depending on context.
How does GM-CSF affect macrophages?
GM-CSF enhances pro-inflammatory responses of macrophages, including to Pseudomonas aeruginosa infection.
What is the link between GM-CSF and cancer?
GM-CSF can promote tumor progression by activating neutrophils that express B7-H4, an immune checkpoint.
How can I model GM-CSF regulation in the lab?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to study GM-CSF regulation.
Conclusion
The positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) is a critical biological process with broad implications in immunity, inflammation, and cancer. Understanding the molecular mechanisms and key genes involved can lead to novel therapeutic strategies. CRISPR-based models provide powerful tools to dissect these pathways and identify new drug targets.
References
- 1. Fan Q et al.. 2019. Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration.. Circulation 139(5):663-678 PMID: 30586706
- 2. Seledtsov VI et al.. 2019. Directs effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on adaptive immunogenesis.. Hum Vaccin Immunother 15(12):2903-2909 PMID: 31063025
- 3. Takahashi A et al.. 1995. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2.. Blood 86(2):607-16 PMID: 7605990
- 4. Liu Q et al.. 2017. The effect of granulocyte and granulocyte-macrophage colony stimulating factors on tumor promotion.. J BUON 22(1):21-28 PMID: 28365931
- 5. Seledtsov VI et al.. 2019. Granulocyte colony-stimulating factor downregulates interferon-gamma receptor expression and stimulates interleukin-6 production in activated human macrophages.. Growth Factors 37(3-4):164-169 PMID: 31530205
- 6. Singh S et al.. 2015. Granulocyte-macrophage colony stimulatory factor enhances the pro-inflammatory response of interferon-γ-treated macrophages to Pseudomonas aeruginosa infection.. PLoS One 10(2):e0117447 PMID: 25706389
- 7. Kaushansky K. 1989. Control of granulocyte-macrophage colony-stimulating factor production in normal endothelial cells by positive and negative regulatory elements.. J Immunol 143(8):2525-9 PMID: 2677143
- 8. Shan ZG et al.. 2021. Granulocyte-Macrophage Colony-Stimulating Factor-Activated Neutrophils Express B7-H4 That Correlates with Gastric Cancer Progression and Poor Patient Survival.. J Immunol Res 2021:6613247 PMID: 33763491
